BDBM50158869 CHEMBL3786182::US10836743, Compound GSK-2879552::US11254676, Example Control::US11873292, Compound GSK2879552
SMILES OC(=O)c1ccc(CN2CCC(CN[C@@H]3C[C@H]3c3ccccc3)CC2)cc1
InChI Key InChIKey=LRULVYSBRWUVGR-FCHUYYIVSA-N
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 3 hits for monomerid = 50158869
TargetLysine-specific histone demethylase 1A(Homo sapiens (Human))
Shanghai Institute of Materia Medica
US Patent
Shanghai Institute of Materia Medica
US Patent
Affinity DataIC50: 404nMAssay Description:Principle: LSD1 specifically removes the methylation modification at K4 lysine on H3 polypeptide substrate, making it a substrate without methylation...More data for this Ligand-Target Pair
TargetAmine oxidase [flavin-containing] A(Homo sapiens (Human))
Shanghai Institute of Materia Medica
US Patent
Shanghai Institute of Materia Medica
US Patent
Affinity DataIC50: >1.00E+5nMAssay Description:Principle: A specific luciferin derivative was used as a substrate. MAOA or MAOB can catalyze the conversion of substrate to luciferin methyl ester. ...More data for this Ligand-Target Pair
TargetAmine oxidase [flavin-containing] B(Homo sapiens (Human))
Shanghai Institute of Materia Medica
US Patent
Shanghai Institute of Materia Medica
US Patent
Affinity DataIC50: >1.00E+5nMAssay Description:Principle: A specific luciferin derivative was used as a substrate. MAOA or MAOB can catalyze the conversion of substrate to luciferin methyl ester. ...More data for this Ligand-Target Pair